Characterizing the mechanism and the clinical relevance of the synthetic lethal interaction between STAT3 inhibition and HER2 overexpression in breast cancers

被引:1
|
作者
Barrueco, Ruth Rodriguez [1 ]
Yu, Jiyang [1 ]
Alvarez, Mariano [1 ]
Castro, Veronica [1 ]
Marshall, Netonia [1 ]
Su, Ruoxi [1 ]
Castro, Laura [1 ]
Maurer, Matthew [1 ]
Califano, Andrea [1 ]
Silva, Jose M. [1 ]
机构
[1] Columbia Univ, New York, NY USA
关键词
D O I
10.1158/1538-7445.AM2014-2761
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2761
引用
收藏
页数:2
相关论文
共 46 条
  • [41] Induction of caspase-dependent extrinsic apoptosis by apigenin through inhibition of signal transducer and activator of transcription 3 (STAT3) signalling in HER2-overexpressing BT-474 breast cancer cells
    Seo, Hye-Sook
    Jo, Jae Kyung
    Ku, Jin Mo
    Choi, Han-Seok
    Choi, Youn Kyung
    Woo, Jong-Kyu
    Kim, Hyo In
    Kang, Soo-yeon
    Lee, Kang Min
    Nam, Koong Won
    Park, Namkyu
    Jang, Bo-Hyoung
    Shin, Yong Cheol
    Ko, Seong-Gyu
    BIOSCIENCE REPORTS, 2015, 35
  • [42] Transcriptome- and proteome-oriented identification of dysregulated eIF4G, STAT3, and Hippo pathways altered by PIK3CAH1047R in HER2/ER-positive breast cancer
    Feixiong Cheng
    Junfei Zhao
    Ariella B. Hanker
    Monica Red Brewer
    Carlos L. Arteaga
    Zhongming Zhao
    Breast Cancer Research and Treatment, 2016, 160 : 457 - 474
  • [43] A strong correlation between expression of Wntless and of human epidermal growth factor receptor 2 in gastric, ovarian, and breast cancers suggests a novel-signalling pathway involving NFκB and STAT3
    Stewart, Jonathan
    James, Jacqueline
    McCluggage, Glenn
    McQuaid, Stephen
    Boyle, David
    Arthur, Kenneth
    Mullan, Paul
    Kidson, Claire
    McCabe, Nuala
    Kennedy, Richard
    McArt, Darragh
    Carson, Anne
    Yan, Benedict
    Lei Zhengdeng
    Tan, Patrick
    Virshup, David
    Salto-Tellez, Manuel
    LANCET, 2013, 381 : 106 - 106
  • [44] Transcriptome- and proteome-oriented identification of dysregulated eIF4G, STAT3, and Hippo pathways altered by PIK3CA H1047R in HER2/ER-positive breast cancer
    Cheng, Feixiong
    Zhao, Junfei
    Hanker, Ariella B.
    Brewer, Monica Red
    Arteaga, Carlos L.
    Zhao, Zhongming
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 160 (03) : 457 - 474
  • [45] tGLI1 and IL-6/IL-6R/GP130/STAT3 pathways cooperate to promote breast cancer stem cells and are co-activated in HER2-enriched and triple-negative breast cancers
    Manore, Sara G.
    Doheny, Daniel L.
    Zhu, Dongqin
    Wong, Grace L.
    Regua, Angelina T.
    Arrigo, Austin
    Wagner, Calvin J.
    Najjar, Mariana
    Lo, Hui-Wen
    CANCER RESEARCH, 2022, 82 (12)
  • [46] Tamoxifen-induced ER-α-SRC3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence (vol 13, pg 1135, 2006)
    McIlroy, Marie
    Fleming, Fergal J.
    Buggy, Yvonne
    Hill, Arnold D. K.
    Young, Leonie S.
    ENDOCRINE-RELATED CANCER, 2014, 21 (05) : X1 - X3